Kennerdell J S, Johnson B L, Deutsch M
Ophthalmology. 1979 May;86(5):942-7. doi: 10.1016/s0161-6420(79)35439-2.
Ten patients with biopsy-proved lymphoid hyperplasia (pseudotumor) of the orbit were treated with radiation therapy individed sose ranging from 2,500 to 3,000 rads. Five of the ten patients had prior treatment with corticosteroids in high dosages with only partial or no response. All ten patients had clinical resolution of the lymphoid hyperplasia orbital mass within three weeks following radiation therapy. A follow-up period of six months to five years has demonstrated no recurrences. There were no discernible complications from the radiation therapy. We believe that radiation therapy should be considered as a primary treatment of benign lymphoid hyperplasia of the orbit.
10例经活检证实为眼眶淋巴样增生(假瘤)的患者接受了放射治疗,剂量范围为2500至3000拉德。10例患者中有5例之前接受过高剂量皮质类固醇治疗,但仅部分缓解或无反应。所有10例患者在放射治疗后3周内眼眶淋巴样增生肿块均临床消退。随访6个月至5年未发现复发。放射治疗未出现明显并发症。我们认为放射治疗应被视为眼眶良性淋巴样增生的主要治疗方法。